158
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin

, , , , , , & show all
Pages 415-425 | Received 29 Apr 2014, Accepted 20 Jun 2014, Published online: 25 Aug 2014

REFERENCES

  • Folkman J, Shing Y: Angiogenesis. J Biol Chem. 1992;267(16): 10931–10934.
  • Nijmeh J, Moldobaeva A, Wagner EM: Role of ROS in ischemia-induced lung angiogenesis. Am J Physiol Lung Cell Mol Physiol. 2010;299(4):L535–L541.
  • Perino MG, Moldobaeva A, Jenkins J, Wagner EM: Chemokine localization in bronchial angiogenesis. PLoS One. 2013;8(6): e66432.
  • Ghelfi E, Yu CW, Elmasri H, Terwelp M, Lee CG, Bhandari V, Comhair SA, Erzurum SC, Hotamisligil GS, Elias JA, Cataltepe S: Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma. Am J Pathol. 2013;182(4):1425–1433.
  • Keglowich L, Roth M, Philippova M, Resink T, Tjin G, Oliver B, Lardinois D, Dessus-Babus S, Gosens R, Hostettler Haack K, Tamm M, Borger P: Bronchial smooth muscle cells of asthmatics promote angiogenesis through elevated secretion of CXC-Chemokines (ENA-78, GRO-alpha, and IL-8). PLoS One. 2013;8(12):e81494.
  • McDonald DM: Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med. 2001;164(10 Pt 2):S39–S45.
  • Turner-Warwick M: Precapillary systemic-pulmonary anastomoses. Thorax. 1963;18:225–237.
  • Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, Goetinck P: Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest. 2001;107(2):R9–R14.
  • Lee PC, Salyapongse AN, Bragdon GA, Shears LL, 2nd, Watkins SC, Edington HD, Billiar TR: Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol. 1999;277(4 Pt 2):H1600–H1608.
  • Zhou Z, Wang J, Cao R, Morita H, Soininen R, Chan KM, Liu B, Cao Y, Tryggvason K: Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res. 2004;64(14):4699–4702.
  • Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H: Keloids: current concepts of pathogenesis (review). Int J Mol Med. 2009;24(3):283–293.
  • Tuan TL, Nichter LS: The molecular basis of keloid and hypertrophic scar formation. Mol Med Today. 1998;4(1):19–24.
  • Henke C, Fiegel V, Peterson M, Wick M, Knighton D, McCarthy J, Bitterman P: Identification and partial characterization of angiogenesis bioactivity in the lower respiratory tract after acute lung injury. J Clin Invest. 1991;88(4):1386–1395.
  • Keane MP, Belperio JA, Moore TA, Moore BB, Arenberg DA, Smith RE, Burdick MD, Kunkel SL, Strieter RM: Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol. 1999;162(9):5511–5518.
  • Hamada N, Kuwano K, Yamada M, Hagimoto N, Hiasa K, Egashira K, Nakashima N, Maeyama T, Yoshimi M, Nakanishi Y: Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice. J Immunol. 2005;175(2):1224–1231.
  • Peao MN, Aguas AP, de Sa CM, Grande NR: Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec. 1994;238(1):57–67.
  • Schraufnagel DE, Mehta D, Harshbarger R, Treviranus K, Wang NS: Capillary remodeling in bleomycin-induced pulmonary fibrosis. Am J Pathol. 1986;125(1):97–106.
  • Janssen WJ, Barthel L, Muldrow A, Oberley-Deegan RE, Kearns MT, Jakubzick C, Henson PM: Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am J Respir Crit Care Med. 2011;184(5):547–560.
  • Moore BB, Hogaboam CM: Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294(2): L152–L160.
  • Hyde DM, Blozis SA, Avdalovic MV, Putney LF, Dettorre R, Quesenberry NJ, Singh P, Tyler NK: Alveoli increase in number but not size from birth to adulthood in rhesus monkeys. Am J Physiol Lung Cell Mol Physiol. 2007;293(3):L570–L579.
  • Hsia CC, Hyde DM, Ochs M, Weibel ER: How to measure lung structure–what for? On the “Standards for the quantitative assessment of lung structure.” Respir Physiol Neurobiol. 2010;171(2):72–74.
  • Garlanda C, Dejana E: Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol. 1997;17(7): 1193–1202.
  • Motoike T, Loughna S, Perens E, Roman BL, Liao W, Chau TC, Richardson CD, Kawate T, Kuno J, Weinstein BM, Stainier DY, Sato TN: Universal GFP reporter for the study of vascular development. Genesis. 2000;28(2):75–81.
  • Carmeliet P: Angiogenesis in health and disease. Nat Med. 2003;9(6):653–660.
  • Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85(3):221–228.
  • Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME, Gurtner GC: Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood. 2005;105(3): 1068–1077.
  • Asahara T, Kawamoto A, Masuda H: Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells. 2011;29(11):1650–1655.
  • Semenza GL: Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem. 2007;102(4):840–847.
  • Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y, Satake M, Suda T: A role for hematopoietic stem cells in promoting angiogenesis. Cell. 2000;102(2):199–209.
  • Rehman J, Li J, Orschell CM, March KL: Peripheral blood “endothelial progenitor cells” are derived from monocyte/ macrophages and secrete angiogenic growth factors. Circulation. 2003;107(8):1164–1169.
  • Wong VW, Crawford JD: Vasculogenic cytokines in wound healing. Biomed Res Int. 2013;2013:190486.
  • Bompais H, Chagraoui J, Canron X, Crisan M, Liu XH, Anjo A, Tolla-Le Port C, Leboeuf M, Charbord P, Bikfalvi A, Uzan G: Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood. 2004;103(7):2577–2584.
  • Hsia CC, Hyde DM, Ochs M, Weibel ER: An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med. 2010;181(4): 394–418.
  • Muhlfeld C, Weibel ER, Hahn U, Kummer W, Nyengaard JR, Ochs M: Is length an appropriate estimator to characterize pulmonary alveolar capillaries? A critical evaluation in the human lung. Anat Rec (Hoboken). 2010;293(7):1270–1275.
  • Orfanos SE, Mavrommati I, Korovesi I, Roussos C: Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive Care Med. 2004;30(9):1702–1714.
  • Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, Zemans RL, Bowman JC, Koyanagi DE, Yunt ZX, Smith LP, Cheng SS, Overdier KH, Thompson KR, Geraci MW, Douglas IS, Pearse DB, Tuder RM: The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 2012;18(8): 1217–1223.
  • Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721–732.
  • Coulon C, Georgiadou M, Roncal C, De Bock K, Langenberg T, Carmeliet P: From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery. Arterioscler Thromb Vasc Biol. 2010;30(12):2331–2336.
  • Burdick MD, Murray LA, Keane MP, Xue YY, Zisman DA, Belperio JA, Strieter RM: CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am J Respir Crit Care Med. 2005;171(3):261–268.
  • Wang X, Zhu H, Yang X, Bi Y, Cui S: Vasohibin attenuates bleomycin induced pulmonary fibrosis via inhibition of angiogenesis in mice. Pathology. 2010;42(5):457–462.
  • Ou XM, Li WC, Liu DS, Li YP, Wen FQ, Feng YL, Zhang SF, Huang XY, Wang T, Wang K, Wang X, Chen L: VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Int Immunopharmacol. 2009;9(1):70–79.
  • Johnson A, DiPietro LA: Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J. 2013;27(10):3893–3901.
  • Willenborg S, Lucas T, van Loo G, Knipper JA, Krieg T, Haase I, Brachvogel B, Hammerschmidt M, Nagy A, Ferrara N, Pasparakis M, Eming SA: CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood. 2012;120(3):613–625.
  • Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W, Roers A, Eming SA: Differential roles of macrophages in diverse phases of skin repair. J Immunol. 2010;184(7):3964–3977.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.